Posts

Odyssey Therapeutics Secures $279M IPO Amid Biotech Funding Challenges

on

The NewCo Model in Chinese Biotech: A Transformative Exit Strategy for Global Expansion

on

Jeito Capital Raises Record $1.2 Billion for Jeito II Fund, Largest Ever for Independent European Biopharma Fund

on

"We need to put some bad ideas to bed": Inside Incubate's battles for biotech on Capitol Hill

on

European VCs Launch Life Sciences Coalition to Boost Homegrown Biotech Investment

on

Surge in Investments Driving Genetic and Pharma Innovations in 2026

on

VC Funding Uptick in Back Half of 2025 Has Analysts Hopeful for 2026

on

Solve Therapeutics Raises $120M to Advance Next-Generation ADCs for Solid Tumors

on

Spotlight On: VC Deal Flow – October's Haul Sets 2025 up to Run Rings Around Previous Year

on

Apptronik Raises $350 Million Series A to Scale AI Humanoid Robot Production

on

Ascenta Capital Closes $325 Million Inaugural Fund to Back Exceptional Development-Stage Biotechs

on

Getting to Yes: How Deal-Making Fuels Biotech Growth – 2025 Updates

on

Sanofi Injects $625M Into Biotech Investment Arm to Accelerate Innovation

on

Fierce Biotech Fundraising Tracker '25: Avenzo adds $60M Series B; Ollin debuts with $100M

on

Langers Team Launch $77.5M Fund to Invest at Intersection of Technology and Biology

on

Fierce Biotech Fundraising Tracker '25: CHARM attracts $80M; Wugen reels in $115M

on

Hatteras Raises $200M for Two New Funds Following HistoSonics Exit Success

on

Frazier Life Sciences Raises $1.3 Billion Amid Biotech Downturn

on